Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM

1 3 月, 2026

One Min Read

11 Views

原文: https://finance.yahoo.com/news/pfizer-inc-pfe-astellas-pharma-092754566.html

Last Update: 1 3 月, 2026

Written By

Other Articles

Previous

Why Eni S.p.A. (E) is One of the Best Cheap Stocks Under $50 to Buy Right Now

Next

Novo Nordisk A/S (NVO) Announces FDA Approval of Three New Indications for Sogroya

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept